Table 1:
Hormone | Intra-assay C.V. | Inter-assay C.V. | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
17β estradiol (pg/mL) | 0.23 | 0.50 | 0.74 | 35 | 151 | 405 | 0.29 | 0.50 | 0.77 | 32 | 140 | 382 |
Variation (%) | 11.8 | 7.3 | 6.0 | 1.6 | 1.5 | 1.4 | 10.8 | 8.5 | 6.9 | 5.1 | 4.6 | 4.8 |
Estrone (pg.mL) | 0.30 | 0.50 | 0.84 | 32 | 142 | 389 | 0.25 | 0.51 | 0.85 | 30 | 131 | 355 |
Variation (%) | 17.8 | 7.5 | 6.1 | 2.5 | 1.7 | 1.2 | 12.0 | 9.5 | 7.9 | 7.4 | 7.1 | 6.6 |
Follicle Stimulating Hormone (mIU/mL) | 8.6 | 47.1 | 6.5 | 16.7 | 58.0 | |||||||
Variation (%) | 32. | 2.8 | 3.6 | 3.2 | 4.7 | |||||||
Luteinizing Hormone (mIU/mL) | 1.2 | 38.5 | 1.4 | 15.6 | 48.8 | |||||||
Variation (%) | 4.3 | 4.0 | 9.3 | 6.0 | 6.0 | |||||||
Testosterone, high sensitivity (ng/dL) | 0.65 | 4.3 | 48 | 118 | 832 | 0.69 | 4.3 | 45 | 117 | 841 | ||
Variation (%) | 7.4 | 6.1 | 9.0 | 2.3 | 0.9 | 8.9 | 6.9 | 4.0 | 3.6 | 3.5 |
Reused with permission from: Kling JM, Dowling NM, Bimonte-Nelson HA, et al. Impact of Menopausal Hormone Formulations on Pituitary-Ovarian Regulatory Feedback. Am J Physiol Regul Integr Comp Physiol. 2019;doi: 10.1152/ajpregu.00234.2019
C.V. = coefficient of variability